$13.25
In chiusura: Nov 7, 5:17 PM EDT
$13.50
0.251.89%
Pre-mercato: Nov 7, 5:17 PM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
Phathom Pharmaceuticals segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
ott 30
EPS
$-0.150
Ricavi trimestrali
$49.50M
Ricavi annuali
(a partire da set 30)
(a partire da set 30)
$147.19M
Analizza lo storico degli utili di Phathom Pharmaceuticals utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
PHAT | Phathom Pharmaceuticals | -$1.05 | -$0.41 | -$0.15 | 63.41% | $16.35M | $47.87M | $49.50M | 3.41% | 10/30/2025 | |
PHAT | Phathom Pharmaceuticals | -$1.25 | -$0.88 | -$0.79 | 10.23% | $7.32M | $35.85M | $39.50M | 10.18% | 08/07/2025 | |
PHAT | Phathom Pharmaceuticals | -$1.11 | -$1.07 | -$1.07 | 0.00% | $1.91M | $29.02M | $28.52M | -1.73% | 05/01/2025 | |
PHAT | Phathom Pharmaceuticals | -$0.80 | -$1.08 | -$0.79 | 26.85% | $682.00K | $25.65M | $29.66M | 15.65% | 03/06/2025 | |
PHAT | Phathom Pharmaceuticals | -$0.54 | -$1.49 | -$1.05 | 29.53% | $0.00 | $12.61M | $16.35M | 29.67% | 11/07/2024 | |
PHAT | Phathom Pharmaceuticals | -$0.84 | -$1.38 | -$1.25 | 9.42% | $0.00 | $5.81M | $7.32M | 26.06% | 08/08/2024 | |
PHAT | Phathom Pharmaceuticals | -$0.89 | -$1.24 | -$1.42 | -14.52% | $0.00 | $2.05M | $1.91M | -6.73% | 05/09/2024 | |
PHAT | Phathom Pharmaceuticals | -$1.33 | -$1.08 | -$1.39 | -28.70% | $0.00 | $410.00K | $682.00K | 66.34% | 03/07/2024 | |
PHAT | Phathom Pharmaceuticals | -$1.32 | -$0.89 | -$0.76 | 14.61% | $0.00 | — | $0.00 | — | 11/09/2023 | |
PHAT | Phathom Pharmaceuticals | -$1.33 | -$1.00 | -$0.84 | 16.00% | $0.00 | — | $0.00 | — | 08/10/2023 | |
PHAT | Phathom Pharmaceuticals | -$1.07 | -$1.26 | -$0.89 | 29.37% | $0.00 | — | $0.00 | — | 05/10/2023 | |
PHAT | Phathom Pharmaceuticals | -$0.95 | -$1.35 | -$1.33 | 1.48% | $0.00 | — | $0.00 | — | 02/28/2023 | |
PHAT | Phathom Pharmaceuticals | -$0.98 | -$1.32 | -$1.32 | 0.00% | $0.00 | — | $0.00 | — | 11/08/2022 | |
PHAT | Phathom Pharmaceuticals | -$1.00 | -$1.03 | -$1.33 | -29.13% | $0.00 | — | $0.00 | — | 08/02/2022 | |
PHAT | Phathom Pharmaceuticals | -$0.96 | -$0.97 | -$1.07 | -10.31% | $0.00 | $210.00K | $0.00 | -100.00% | 05/10/2022 | |
PHAT | Phathom Pharmaceuticals | -$1.58 | -$1.03 | -$0.95 | 7.77% | $0.00 | — | $0.00 | — | 03/01/2022 | |
PHAT | Phathom Pharmaceuticals | -$1.02 | -$0.98 | -$0.98 | 0.00% | $0.00 | — | $0.00 | — | 11/08/2021 | |
PHAT | Phathom Pharmaceuticals | -$0.64 | -$1.07 | -$1.00 | 6.54% | $0.00 | — | $0.00 | — | 08/10/2021 | |
PHAT | Phathom Pharmaceuticals | -$0.62 | -$1.19 | -$0.96 | 19.33% | $0.00 | — | $0.00 | — | 05/11/2021 | |
PHAT | Phathom Pharmaceuticals | -$3.97 | — | -$1.58 | — | $0.00 | — | $0.00 | — | 03/30/2021 | |
PHAT | Phathom Pharmaceuticals | -$1.07 | — | -$1.02 | — | $0.00 | — | $0.00 | — | 11/10/2020 |
Phathom Pharmaceuticals (PHAT) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | 2025-10-30 | $-0.15 | $-0.41 | 63.4 % |
| Q2 | 2025-08-07 | $-0.79 | $-0.88 | 10.2 % |
| Q1 | 2025-05-01 | $-1.07 | $-1.07 | 0.00 % |
| Q4 | 2025-03-06 | $-0.79 | $-1.08 | 26.9 % |
Phathom Pharmaceuticals (PHAT) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q3 | 2025-10-30 | $49.50M | $47.87M | 3.41 % |
| Q2 | 2025-08-07 | $39.50M | $35.85M | 10.2 % |
| Q1 | 2025-05-01 | $28.52M | $29.02M | -1.73 % |
| Q4 | 2025-03-06 | $29.66M | $25.65M | 15.7 % |
FAQ
Quando Phathom Pharmaceuticals (NASDAQ:PHAT) riporterà gli utili?
Phathom Pharmaceuticals (PHAT) non ha ancora previsto report sulle performance. L'ultimo report sui risultati è stato pubblicato il ottobre 30, 2025 per il Q3.
Quali sono stati gli ultimi utili per azione (EPS) di Phathom Pharmaceuticals (NASDAQ:PHAT)?
Phathom Pharmaceuticals (PHAT) non ha ancora in programma alcun report sugli utili. L'ultimo report sugli utili è stato pubblicato il ottobre 30, 2025 per il Q3 e l'EPS effettivo è stato $-0.15, che superato la stima di $-0.41.
Quali sono state le entrate di Phathom Pharmaceuticals (NASDAQ:PHAT)?
Phathom Pharmaceuticals (PHAT) non ha ancora pianificato alcun report sugli utili. L'ultimo report sugli utili è stato pubblicato il ottobre 30, 2025 per il Q3 e i ricavi effettivi sono stati $49.5M, che superato la stima di $47.9M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.